Girish Sati - Publications

Affiliations: 
2017 Chemistry Wayne State University, Detroit, MI, United States 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Quirke JCK, Sati GC, Sonousi A, Gysin M, Haldimann K, Bottger EC, Vasella A, Hobbie SN, Crich D. Structure-Activity Relationships for 5''-Modifications of 4,5-Aminoglycoside Antibiotics. Chemmedchem. PMID 35385605 DOI: 10.1002/cmdc.202200120  0.631
2021 Lubriks D, Zogota R, Sarpe VA, Matsushita T, Sati GC, Haldimann K, Gysin M, Böttger EC, Vasella A, Suna E, Hobbie SN, Crich D. Synthesis and Antibacterial Activity of Propylamycin Derivatives Functionalized at the 5''- and Other Positions with a View to Overcoming Resistance Due to Aminoglycoside Modifying Enzymes. Acs Infectious Diseases. PMID 34114793 DOI: 10.1021/acsinfecdis.1c00158  0.61
2019 Waduge P, Sati GC, Crich D, Chow CS. Use of a fluorescence assay to determine relative affinities of semisynthetic aminoglycosides to small RNAs representing bacterial and mitochondrial A sites. Bioorganic & Medicinal Chemistry. 115121. PMID 31610941 DOI: 10.1016/J.Bmc.2019.115121  0.422
2019 Sati GC, Sarpe VA, Furukawa T, Mondal S, Mantovani M, Hobbie SN, Vasella A, Böttger EC, Crich D. Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics to Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity. Acs Infectious Diseases. PMID 31436080 DOI: 10.1021/Acsinfecdis.9B00128  0.61
2019 Matsushita T, Sati G, Kondasinghe N, Pirrone M, Kato T, Waduge P, Kumar H, Sanchon A, Dobosz-Bartoszek M, Shcherbakov D, Juhas M, Hobbie SN, Schrepfer T, Chow CS, Polikanov Y, et al. Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens. Journal of the American Chemical Society. PMID 30793894 DOI: 10.1021/jacs.9b01693  0.615
2018 Anneken JH, Angoa-Perez M, Sati GC, Crich D, Kuhn DM. Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice. Psychopharmacology. PMID 30074064 DOI: 10.1007/S00213-018-4991-8  0.339
2017 Anneken JH, Angoa-Perez M, Sati GC, Crich D, Kuhn DM. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine. Neuropharmacology. PMID 28851615 DOI: 10.1016/J.Neuropharm.2017.08.033  0.384
2017 Sati GC, Scherbakov D, Hobbie SN, Vasella A, Böttger EC, Crich D. N6', N6''' and O4' Modifications to Neomycin Affect Ribosomal Selectivity Without Compromising Antibacterial Activity. Acs Infectious Diseases. PMID 28343384 DOI: 10.1021/Acsinfecdis.6B00214  0.548
2016 Anneken JH, Angoa-Perez M, Sati GC, Crich D, Kuhn DM. Dissecting the influence of two structural substituents on the differential neurotoxic effects of methamphetamine and mephedrone on dopamine nerve endings with the use of 4-methylmethamphetamine and methcathinone. The Journal of Pharmacology and Experimental Therapeutics. PMID 28039330 DOI: 10.1124/Jpet.116.237768  0.424
2015 Sati GC, Crich D. Facile Synthesis of 3-N-Alkyl Pyrimidin-2,4-diones from N-Sulfonyloxy Maleimides and Amines. Organic Letters. 17: 4122-4. PMID 26267613 DOI: 10.1021/acs.orglett.5b02079  0.371
Show low-probability matches.